TriSalus Life Sciences, Inc. (TLSI) Gross margin 2022–2025
TriSalus Life Sciences, Inc. (TLSI) gross margin by fiscal year — reported gross profit divided by reported revenue.
84.6%FY2025 · since FY2022: 81.8% → 84.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 84.6% | -1.5 pp |
| FY2024 | 86.1% | +0.1 pp |
| FY2023 | 85.9% | +4.1 pp |
| FY2022 | 81.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice